Healthcare -
Biotechnology - NASDAQ - US
$ 0.6625
-2.17 %
$ 51.8 M
Market Cap
4.14
P/E
CTMX - RESEARCH & DEVELOPMENT
Research & Development CTMX - CytomX Therapeutics, Inc.
77.7 M
LAST VALUE
-17.52%
2 YEAR CAGR
-5.64%
5 YEAR CAGR
21.71%
10 YEAR CAGR